Inventor · disambiguated record
Marc E. Uknis
Also filed as: UKNIS MARC · UKNIS MARC E
8 granted patents·5 pending applications·6 citations·filing 2005–2023
80Inventor score
Files withUNIV MASSACHUSETTS6SHIRE VIROPHARMA INC3CSL BEHRING LLC2CSL BEHRING GMBH1VIROPHARMA HOLDINGS LTD1
Top patents by PatentIndex Score
13 records- 0182US8361976B2Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference moleculesUNIV MASSACHUSETTS·Filed 2005·Granted Jan 29, 2013·3 cites·28 claims
- 0281US12084660B2Therapeutic alteration of transplantable tissues through In Situ or Ex Vivo exposure to RNA interference moleculesUNIV MASSACHUSETTS·Filed 2022·Granted Sep 10, 2024·0 cites·11 claims
- 0376US8940709B2Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference moleculesUNIV MASSACHUSETTS·Filed 2013·Granted Jan 27, 2015·1 cites·6 claims
- 0472US11220686B2Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference moleculesUNIV MASSACHUSETTS·Filed 2019·Granted Jan 11, 2022·0 cites·14 claims
- 0572US9895428B2Methods of treating antibody-mediated rejection in organ transplant patients with C1-esterase inhibitorSHIRE VIROPHARMA INC·Filed 2014·Granted Feb 20, 2018·2 cites·27 claims
- 0662US10260066B2Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference moleculesUNIV MASSACHUSETTS·Filed 2015·Granted Apr 16, 2019·0 cites·9 claims
- 0760US9150861B2Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference moleculesUNIV MASSACHUSETTS·Filed 2015·Granted Oct 6, 2015·0 cites·6 claims
- 0860US2024238395A1Methods for Reducing Risk of Onset of Acute Graft Versus Host Disease After Hematopoeitic Cell TransplantationCSL BEHRING LLC·Filed 2023·Application pending·0 cites
- 0959US2020360495A1Methods of treating antibody-mediated rejection in organ transplant patients with c1-esterase inhibitorSHIRE VIROPHARMA INC·Filed 2020·Application pending·0 cites
- 1053US11857610B2Methods for reducing risk of onset of acute graft versus host disease after hematopoietic cell transplantationCSL BEHRING LLC·Filed 2018·Granted Jan 2, 2024·0 cites·11 claims
- 1151US2024000908A1Method for Treating Antibody-Mediated RejectionCSL BEHRING GMBH·Filed 2021·Application pending·0 cites
- 1250US2018104319A1Methods of treating antibody-mediated rejection in organ transplant patients with c1-esterase inhibitorSHIRE VIROPHARMA INC·Filed 2017·Application pending·0 cites
- 1349US2015104445A1Methods of inhibiting the alternative pathway of complement immune system activation and compositions used thereinVIROPHARMA HOLDINGS LTD·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marc E. Uknis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →